tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksTop Gainers/ Losers/ Active StocksMost Visited WebsitesTipRanks Momentum IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Pro Newsletters
Smart Investor
Popular
Smart Growth
New
Research Tools
Stock ScreenerETF Screener
Popular
Trending StocksDaily Analyst RatingsCompare StocksCompare ETFsPenny Stock ScreenerTechnical Analysis ScreenerDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsTop Online BrokersBecome an Affiliate
Follow Us
NewsTrendingPortfolio
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Notification Center
Top ETFs
Top Smart Score Stocks
Popular
Earnings
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Plans & Pricing
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Top Gainers/ Losers/ Active Stocks
Most Visited Websites
TipRanks Momentum Index
Dividend Stocks
AI Stocks
Largest Companies by Market Cap
ETFs
ETF Center
Top ETFs by Upside
New
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Options
Options Market Overview
Unusual Options Activity
Popular
Most Active Options
Options Volume Leaders
Commodities
Gold
New
Crypto
Crypto Center
Bitcoin
Popular
Ethereum
Currency
Currency Center
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Stock Screener
ETF Screener
Popular
Trending Stocks
Daily Analyst Ratings
Compare Stocks
Compare ETFs
Penny Stock Screener
Technical Analysis Screener
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Economic Indicators
Economic Indicators Center
Inflation Rate
Unemployment Rate
Federal Funds Rate
Class Actions
Class Actions
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Dollar Cost Averaging
New
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
News
Portfolio
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Calculators
Compound Interest Calculator
New
Mortgage Calculator
Popular
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
Follow Us

SYRE Stock Latest News

Spyre Therapeutics 7.275M share Spot Secondary priced at $27.50
The FlySpyre Therapeutics 7.275M share Spot Secondary priced at $27.50
4d ago
SYRE
Spyre Therapeutics Faces Internal Control Challenges
PremiumCompany Announcements
Spyre Therapeutics Faces Internal Control Challenges
4d ago
8K
SYRE
Spyre Therapeutics announces $200M common stock offering
PremiumThe Fly
Spyre Therapeutics announces $200M common stock offering
4d ago
SYRE
Spyre Therapeutics price target raised to $65 from $50 at Baird
PremiumThe Fly
Spyre Therapeutics price target raised to $65 from $50 at Baird
10d ago
SYRE
Spyre Therapeutics Reports Promising Trial Results for SPY001
PremiumCompany Announcements
Spyre Therapeutics Reports Promising Trial Results for SPY001
11d ago
8K
SYRE
Spyre Therapeutics’ SPY001 shows efficacy, safety in Phase 1 bowel disease trial
PremiumThe FlySpyre Therapeutics’ SPY001 shows efficacy, safety in Phase 1 bowel disease trial
11d ago
SYRE
Spyre Therapeutics Advances IBD Treatment Pipeline
Premium
Company Announcements
Spyre Therapeutics Advances IBD Treatment Pipeline
15d ago
SYRE
Spyre Therapeutics reports Q3 EPS ($1.36), consensus (82c)
Premium
The Fly
Spyre Therapeutics reports Q3 EPS ($1.36), consensus (82c)
15d ago
SYRE
Spyre Therapeutics price target raised to $65 from $50 at Guggenheim
PremiumThe Fly
Spyre Therapeutics price target raised to $65 from $50 at Guggenheim
29d ago
TAK
SYRE
Spyre Therapeutics Advances SPY003 for IBD Treatment
PremiumCompany Announcements
Spyre Therapeutics Advances SPY003 for IBD Treatment
1M ago
8K
SYRE
Spyre Therapeutics expects acceleration of SPY003 clinical timeline
PremiumThe Fly
Spyre Therapeutics expects acceleration of SPY003 clinical timeline
1M ago
SYRE
Spyre Therapeutics appoints Sloan as Chief Medical Officer
PremiumThe Fly
Spyre Therapeutics appoints Sloan as Chief Medical Officer
2M ago
SYRE
Spyre Therapeutics files to sell 46.33M shares of common stock for holders
PremiumThe FlySpyre Therapeutics files to sell 46.33M shares of common stock for holders
2M ago
SYRE
Spyre Therapeutics files $500M mixed securities shelf
Premium
The Fly
Spyre Therapeutics files $500M mixed securities shelf
3M ago
SYRE
Wedbush bullish on Spyre Therapeutics, initiates with an Outperform
Premium
The Fly
Wedbush bullish on Spyre Therapeutics, initiates with an Outperform
3M ago
APGE
SYRE
Spyre Therapeutics initiated with an Outperform at Wedbush
PremiumThe Fly
Spyre Therapeutics initiated with an Outperform at Wedbush
3M ago
SYRE
Spyre Therapeutics management to meet with BTIG
PremiumThe Fly
Spyre Therapeutics management to meet with BTIG
3M ago
SYRE
Spyre Therapeutics reports Q2 EPS (86c), consensus (95c)
PremiumThe Fly
Spyre Therapeutics reports Q2 EPS (86c), consensus (95c)
4M ago
SYRE
Spyre Therapeutics management to meet virtually with BTIG
PremiumThe Fly
Spyre Therapeutics management to meet virtually with BTIG
4M ago
SYRE
Spyre Therapeutics initiated with an Outperform at Evercore ISI
PremiumThe FlySpyre Therapeutics initiated with an Outperform at Evercore ISI
4M ago
SYRE
Spyre Therapeutics doses first patients in Phase 1 trial of bowel disease drug
Premium
The Fly
Spyre Therapeutics doses first patients in Phase 1 trial of bowel disease drug
5M ago
SYRE
Spyre Therapeutics Announces Updated Share Structure
Premium
Company Announcements
Spyre Therapeutics Announces Updated Share Structure
6M ago
8K
SYRE

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >